As both LCFA and LCFA-CoA have high affi nities for membranes, it is unclear how once LCFA are taken up (and/or activated to LCFA-CoA) these ligands are transported to the nuclear envelope and the nucleoplasm to regulate the activity of nuclear receptors such as PPAR ␣ ( 5 ). Studies with transfected cells overexpressing liver fatty acid binding protein (L-FABP) suggest that this cytoplasmic LCFA and LCFA-CoA binding protein may be a likely candidate for directly enhancing the transfer of these ligands into nuclei (12) (13) (14) (15) . Further, transactivation assays and colocalization experiments in transfected cells suggest that L-FABP directly interacts with PPAR ␣ ( 12, 13 ) . However, these studies were performed in transformed, tumorigenic cells, and colocalization by confocal imaging (resolution of 2000 Å) is insuffi cient to demonstrate direct interaction. Because L-FABP protein level is itself regulated by PPAR ␣ transcriptional activity, it has been postulated that L-FABP may mediate its own expression by enhancing LCFA and LCFA-CoA transport into nuclei to facilitate transcriptional activity of PPAR ␣ ( 5 ). Despite these studies, evidence supporting mechanistic details of this hypothesis is lacking. The objective of the present investigation was to use recombinant pure proteins, fl uorescently labeled recombinant proteins, and wild-type (L-FABP +/+ ) and L-FABP gene ablated (L-FABP Ϫ / Ϫ ) mice to begin to resolve some of the mechanistic details of L-FABP-mediated regulation of PPAR ␣ in primary hepatocytes; specifi cally, whether these two proteins directly interacted within nuclei of primary hepatocytes.
MATERIALS AND METHODS

Materials
Palmitic acid (C16:0) was from Sigma-Aldrich (St. Louis, MO). For co-IP, antibodies to the glucocorticoid receptor (GR) and to PPAR ␣ were purchased from Affi nity BioReagents (Golden, CO), while antibodies to sterol regulatory element binding protein-1 (SREBP-1) and to L-FABP were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Mammalian co-IP kit, chemilu minescent substrate, and fi lm were from Pierce Biotechnology (Rockford, IL). For western blotting following co-IP, polyclonal antibodies prepared in rabbit to PPAR ␣ (Affi nity BioReagents) and rabbit polyclonal antiserum to L-FABP ( 16 ) were used in combination with HRP-conjugated anti-rabbit IgG secondary antibodies (Sigma-Aldrich). Cy3 and Cy5 protein labeling kits were from Amersham Biosciences (Piscataway, NJ). For double immunogold EM colocalization experiments, LR White resin, donkey anti-rabbit IgG conjugated to 6nm gold, and donkey anti-goat IgG conjugated to 15nm gold were from Electron Microscopy Sciences (Fort Washington, PA); goat anti-human albumin was from MilesYeda (Rehovot, Israel); and affi nity purifi ed fractions of goat polyclonal antisera to rat L-FABP and rabbit polyclonal antisera to PPAR ␣ and SREBP-1 were obtained from Santa Cruz Biotechnology. For double immunofl uorescence FRET confocal microscopy, Lab-Tek chambered cover glass slides were from Nunc (Naperville, IL); affi nity purifi ed anti-PPAR ␣ and anti-SREBP-1 were from Santa Cruz Biotechnology, and polyclonal anti-L-FABP obtained as described earlier ( 16 ) was affi nity purifi ed on a protein A column according to the manufacturer's instructions (Bio-Rad Laboratories, Hercules, CA). All reagents and solvents used were of the highest grade available and were cell culture tested.
Recombinant proteins
Mouse recombinant L-FABP protein was produced, purifi ed, and delipidated as previously described ( 17 ) . The bacterial expression plasmid for mouse recombinant PPAR ␣ protein (pET-PPAR ␣ ⌬ AB, encoding amino acids 101-468) was a generous gift from Dr. Noa Noy (Case Western University). Mouse PPAR ␣ protein was expressed and purifi ed as previously described ( 6 ) . This truncated version was used for the pure protein studies due to solubility issues with the full-length protein and was expected to show ligand-binding properties identical to those of the fulllength receptor based upon similar experiments with PPAR ␥ ( 18, 19 ) . The bacterial expression plasmid for human recombinant SREBP-1a protein (pGEX4T-SREBP-1a, encoding amino acids 1-460) was generously provided by Dr. Hitoshi Shimano (University of Tsukuba), and the protein was purifi ed as described ( 20 ) . The mature protein was utilized, rather than the full-length protein, as this is the portion of the protein which is tranlocated to the nucleus for transcriptional control ( 20, 21 ) . Protein concentrations were determined by Bradford assay.
Recombinant protein co-immunoprecipitation (co-IP)
To determine whether L-FABP could directly interact with PPAR ␣ in vitro, the ability of the two proteins to co-immunoprecipitate was examined, and recombinant SREBP-1a was used as a negative control. Purifi ed recombinant proteins were combined as follows: L-FABP and PPAR ␣ ; L-FABP and SREBP-1a; and PPAR ␣ and SREBP-1a. Each protein in the combination was examined for the ability to pull down the other protein. For each sample, 20 g of each protein was mixed and allowed to incubate on ice for 10 min prior to co-IP with the antibody-linked resin from the ProFound TM co-IP kit (Pierce Biotechnology, Rockford, IL). Proteins unable to bind to the antibody and proteins eluted from the antibody-linked resin were examined by standard SDS-PAGE and Coomassie blue staining for the presence of each protein.
Circular dichroism (CD)
Circular dichroism was used to examine changes in conformation upon L-FABP and PPAR ␣ interaction using recombinant SREBP-1a as a negative control. A J-710 spectropolarimeter (JASCO Inc., Easton, MD) was used to record circular dichroic spectra of
(fi nal amino acid molarity in each sample was equal to 0.0003 M) in 125 M HEPES, pH 8.0, 12.5 M DTT, 5 mM KCl, 0.3% glycerol at 23°C in a 1 mm cuvette as described previously ( 6, 22 ) . Replicate spectra were recorded ten times over the far-UV region from 186 to 260nm with a 2 nm bandwidth, 10 millidegree sensitivity, 50 nm/min scan rate, and 1 s time constant. The spectral result obtained by averaging the ten scans was used to determine percent composition of ␣ -helices, ␤ -strands, turns, and unordered structures with CDPro software (http://lamar.colostate. edu/~sreeram/CDPro) by the following methods: SELCON3, CDSSTR, and CONTIN/LL ( 23 ) . The CD spectrum of the mixed proteins was compared with a theoretical spectrum of combined but noninteracting proteins. This spectrum was calculated by averaging the spectra of each protein analyzed separately at a concentration equal to that in the mixture ( 22 ) .
Fluorescence resonance energy transfer (FRET)
Recombinant PPAR ␣ , SREBP-1a, and L-FABP proteins were fl uorescently labeled with Cy3 or Cy5 dye using Fluorolink-antibody Cy3 and Cy5 labeling kits (Amersham Biosciences). Absorbance by guest, on January 26, 2018 www.jlr.org
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To evaluate the signifi cance of clusters with two sizes of gold particles in immunogold stains of anti-L-FABP and anti-PPAR ␣ , images of nuclear colocalization patterns were statistically analyzed by the method of Philimonenko, Janacek, and Hozak ( 27 ) . For this, 13 random images of hepatocyte nuclei from immunogold-stained sections were fi lmed. The sites of gold particles in the nucleoplasm (200 µm 2 per group) were manually marked with Adobe Photoshop on layers of digitized versions of these images, and the spatial locations were identifi ed with ImageJ (http://rsb.info.nih.gov/ij/) available from the National Institutes of Health (Bethesda, MD). These data were loaded into the Gold program ( 27 ) for calculating the pair cross-correlation function and the cross-K function to evaluate the level of significance of particle size distributions at various selected distances. Thus the extent of colocalization can be analyzed. For comparison with these measurements of anti-L-FABP and anti-PPAR ␣ labeling, an identical analysis was performed on a similar set of nucleoplasm images from sections that were immunogold-stained with anti-L-FABP and anti-SREBP-1.
Hepatocyte isolation, fi xation, and staining
Hepatocytes from wild-type (L-FABP +/+ ) mice were isolated as described earlier ( 26, 28 ) , seeded (125,000 cells/well) onto collagen-coated 4-well Lab-Tek chambered slides, and incubated overnight at 37°C in a humidifi ed incubator with 5% carbon dioxide. After 24 h, cultured primary hepatocytes were rinsed twice in PBS and fi xed in 4% formaldehyde (methanol-free) with 0.1% glutaraldehyde in 0.1 M sodium phosphate buffer (pH 7.4) for 20 h at 4°C. The fi xed cultures were washed with PBS containing 0.05 M glycine to quench remaining glutaraldehyde autofl uorescence, treated with 5% BSA to block nonspecifi c protein binding, and then incubated for 2 h at room temperature with a mixture of the antibody:dye conjugates in PBS contain ing 0.5% BSA, washed in PBS, and coverslipped with Gel Mount (Polysciences). Controls included (a) hepatocytes individually stained with each antibody and (b) incubations in the absence of antibodies.
Immunofl uorescence confocal microscopy
For FRET determined by laser scanning confocal microscopy, affi nity purifi ed anti-L-FABP was labeled with Cy3 while anti-PPAR ␣ and anti-SREBP-1 were labeled with Cy5 using Fluorolink-antibody Cy3 and Cy5 labeling kits (Amersham Biosciences). The stained hepatocytes were imaged with a laser scanning confocal microscope (LSCM) consisting of an MRC-1024 fl uorescence imaging system (Bio-Rad) with an Axiovert 135 microscope (Zeiss, NY). Excitation light (488, 568, and 647 nm) from a 15-milliwatt krypton-argon laser was delivered to the sample through 63× Zeiss Plan-Fluor oil immersion objective, numerical aperture 1.4.
To estimate the intermolecular distance between L-FABP and PPAR ␣ in hepatocyte nuclei, FRET from Cy3 to Cy5 was detected as sensitized emission of Cy5 (through the 680/32 bandpass fi lter) upon excitation of Cy3 at 488 nm after correction of some bleed through of Cy3 emission through the same fi lter as described earlier ( 22 ) . Quantitative measurements for FRET efficiency estimation were carried out by the acceptor photobleaching method as described ( 22 ) . Cellular images produced by fl uorescence emission of Cy3 (488 nm excitation, 598/40 fi lter) and Cy5 (647 nm excitation, 680/32 fi lter) were sequentially acquired. The cells were then photobleached for 3 min with the 647 nm laser (the conditions of photobleaching were optimized such that a good decrease in Cy5 fl uorescence was obtained without affecting the emission intensity of Cy3), and then the Cy5 and Cy3 post-bleaching images were recorded at their original instrument measurements were used to determine protein concentra tions and dye-to-protein ratios. Emission spectra (560-700 nm) were obtained of 25 nM donor (Cy3-labeled PPAR ␣ , Cy-3-labeled SREBP-1a) in PBS upon excitation at 550 nm with increasing concentration of acceptor (Cy5-labeled L-FABP) in a PC1 photon counting spectrofl uorometer (ISS Inc., Champaign, IL) at 24°C. The spectra were corrected for background (buffer only and acceptor only) and the maximal intensities measured using Vinci 1.5 software (ISS Inc., Champaign, IL). The energy transfer efficiency was calculated using the amount of sensitized acceptor fl uorescence, and the intermolecular distance was calculated according to the Förster equation as described earlier ( 6, 24 ) .
Animals
All animal protocols were approved by the Institutional Animal Care and Use Committee (IACUC) at Texas A&M University.
), generated by targeted disruption of the L-FABP gene through homologous recombination, were obtained as described earlier ( 25, 26 ) . All experiments were performed with livers or hepatocytes derived from N6 backcross generation male mice ranging in age from 2 to 4 months (25-35 g). Hepatocytes from male age-matched, wild-type littermates of the same backcross generation were used as controls. Animals were kept under constant light-dark cycles and had access to food and water ad libitum.
Co-immunoprecipitation
The co-IP of native proteins from mouse liver homogenates was performed as previously described ( 6 ) . Following homogenization of livers, PPAR ␣ and L-FABP were coimmunoprecipitated from liver homogenate (2 mg protein) with antibodies to PPAR ␣ or L-FABP (100 g of antibody) using the ProFound TM mammalian co-IP kit (Pierce Biotechnology, Rockford, IL) according to the manufacturer's instructions. Immunoprecipitated proteins were eluted in 100 l of buffer, and 1/4 of the eluted proteins were loaded onto SDS-PAGE gels and visualized by Western blot for PPAR ␣ and L-FABP. Specifi city of L-FABP co-IP with PPAR ␣ , as well as specifi city of PPAR ␣ for L-FABP, was determined by examination of the eluted proteins by Western blot for other transcription factors (GR; SREBP-1). Specifi city was further examined by immunoprecipitation with antibodies to GR and SREBP-1 followed by Western blotting of eluted proteins for L-FABP as previously described for PPAR ␣ and cofactors ( 6 ) . examined. Again, neither antibody was capable of coimmunoprecipitating both SREBP-1a and PPAR ␣ ( Fig. 1C ) , suggesting that the L-FABP and PPAR ␣ interaction is specifi c.
Immunoelectron microscopy
Circular dichroism: effect of L-FABP interaction with PPAR ␣ on conformation
Different proteins such as L-FABP and PPAR ␣ may interact with or without undergoing conformational changes. This possibility was examined by circular dichroism, a method that determines the secondary structure of proteins. The shapes of the circular dichroic spectra of L-FABP and PPAR ␣ were markedly different, consistent with PPAR ␣ alone having a high content of ␣ -helical structure ( Fig. 2A , closed circles) and L-FABP alone having a high content of ␤ -sheet ( Fig. 2A , open circles). For the mixture containing both proteins, the theoretically expected circular dichroic spectrum based upon the assumption of zero interaction between L-FABP and PPAR ␣ ( Fig. 2B , open circles) was not superimposable upon the experimentally measured spectrum of the combination of L-FABP and PPAR ␣ ( Fig. 2B , closed circles), although only small changes in spectra were observed. Results from the compositional analysis of the ␣ -helices, ␤ -strands, turns, and unordered structures confi rmed small conformational changes in the mixture of these proteins, with a small increase in ␣ -helical structure concomitant with a decrease in unordered structure ( Table 1 ). The presence of small conformational changes upon L-FABP interaction with PPAR ␣ suggests a direct interaction between these proteins. However, the magnitude of these protein-protein conformational changes was 2-to 3-fold smaller than those exhibited by PPAR ␣ in response to LCFA or LCFA-CoA binding ( 6, 8 ) .
The interaction between L-FABP and SREBP-1a was examined to determine specifi city of L-FABP for PPAR ␣ versus other transcription factors. The circular dichroic spectrum of these proteins varied, with SREBP-1a ( Fig. 2C , closed circles) having more unordered structures and L-FABP ( Fig. 2C , open circles) having more ␤ -sheets. However, the spectrum of the experimentally obtained combination of these proteins ( Fig. 2D , closed circles) was superimposable upon the theoretical spectrum for no settings. The image sets were analyzed with ImageJ using the FRETcalculation plugin written by David Stepensky ( 29 ) . FRET effi ciency was calculated from measurements of the increased Cy3 fl uorescence emission after Cy5 photobleaching in 71 different 1 µm 2 regions of 3 hepatocyte nuclei and used to estimate the intermolecular distance between Cy3 and Cy5 (distance ultimately dictated in this experiment by the proximity between the selected protein pair) according to the Förster equation ( 22, 30 ) . To determine the specifi city of the interaction of L-FABP with PPAR ␣ , these methods were repeated with hepatocytes stained with Cy3-anti-L-FABP and Cy5-anti-SREBP-1, and an identical analysis was performed on images with similar staining.
Statistics
Values represented the mean ± SE with n and P indicated as described. Statistical analyses were performed using Student's t -test or two-way ANOVA (ANOVA) (GraphPad Prism, San Diego, CA). Values with P < 0.05 were considered statistically signifi cant.
RESULTS
Co-immunoprecipitation: direct interaction of L-FABP and PPAR ␣ recombinant proteins
One possible mechanism whereby L-FABP expression may infl uence PPAR ␣ -mediated regulation of fatty acid metabolism is through direct interaction of L-FABP with PPAR ␣ . To determine whether L-FABP and PPAR ␣ proteins interact in vitro, recombinant proteins were mixed, precipitated with antibodies to L-FABP or PPAR ␣ , and examined by SDS-PAGE for coprecipitation of both proteins. Whether the antibody to PPAR ␣ or the antibody to L-FABP was used, both proteins were pulled down by the antibody ( Fig. 1A ) , suggesting a direct interaction in vitro. To examine the specifi city of L-FABP for PPAR ␣ versus other transcription factors, the ability of anti-SREBP-1 and anti-L-FABP to pull down SREBP-1a and L-FABP was examined. Neither antibody was capable of co-immunoprecipitating both L-FABP and SREBP-1a ( Fig. 1B ) , suggesting that L-FABP and SREBP-1a do not interact and that the L-FABP inter action with PPAR ␣ is specifi c. To further confi rm the speci fi city of this technique, the ability of anti-SREBP-1 and anti-PPAR ␣ to pull down SREBP-1a and PPAR ␣ was ( Fig. 2F , open circles, P and L w/C16:0 actual) was superimposable upon the experimentally obtained spectrum for L-FABP and PPAR ␣ in the absence of ligand ( Fig. 2F , closed circles, P and L none actual); suggesting that the presence of palmitic acid did not affect the L-FABP-PPAR ␣ interaction. This was further confi rmed by the analysis of the percent composition ( Table 1 ) , which showed no signifi cant difference between the experimentally obtained values in the presence or absence of palmitic acid.
Protein binding assay: effect of L-FABP interaction with PPAR ␣ on conformation
To further examine the effect of protein-protein binding on conformation, these respective recombinant proteins were fl uorescently labeled with Cy3 for the nuclear interaction ( Fig. 2D , open circles) ; suggesting that these proteins do not undergo conformational changes or do not directly interact. Results from the compositional analysis supported this suggestion, as no signifi cant differences were noted ( Table 1 ) .
To determine the effect of LCFA on this interaction, the CD experiment between L-FABP and PPAR ␣ was repeated in the presence of palmitic acid, a strong L-FABP ligand ( 31 ) which is not bound by PPAR ␣ ( 6 ). Although the presence of palmitic acid does not affect PPAR ␣ secondary structure ( 6 ) , the spectrum of L-FABP was strongly altered ( Fig. 2E ) , resulting in strongly decreased ␣ -helical content and a concomitant increase in ␤ -sheets ( Table 1 ) . Upon comparison of these spectra, the experimentally obtained spectrum for L-FABP and PPAR ␣ in the presence of pal- was excited at 550 nm, and an emission spectrum was recorded over the emission range for Cy3-and Cy5-labeled proteins ( Fig. 3E , spectrum 1) . Next, spectra from 560-700 nm were recorded after addition of increasing concentrations of Cy5-L-FABP acceptor ( Fig. 3E , spectra 2-7) . With increasing concentration of the Cy5-L-FABP, decreased Cy3 emission intensity was observed near 575 nm concomitant with the appearance of increasing sensitized emission of Cy5 near 670 nm ( Fig. 3E ) , consistent with FRET between the two fl uorophores. Transformation of the sensitized acceptor emission data into a binding curve revealed that Cy5-L-FABP binding to Cy3-PPAR ␣ was saturable ( Fig. 3F ) with 1:1 stoichiometry ( Fig. 3F , inset) . Quantitative analysis of multiple replicates yielded a K d = 156.5 ± 18.1 nM. Furthermore, the effi ciency of energy transfer was calculated to be E = 44 ± 1% with an interaction distance of r = 52 ± 1Å using the sensitized emission of Cy5, consistent with direct interaction between Cy3-L-FABP and Cy5-PPAR ␣ . Although a slight decrease in Cy3-SREBP-1a fl uorescence intensity was noted at approximately 575 nm with the addition of Cy5-L-FABP, no concomitant increase in sensitized acceptor emission was noted ( Fig. 3G ) . Transformation of the sensitized acceptor emission data into a binding curve revealed that Cy5-L-FABP binding to Cy3-SREBP-1a was not saturable ( Fig. 3H ) , and no binding curve or energy transfer effi ciency could be calculated. Thus, only the direct interaction of PPAR ␣ with L-FABP resulted in FRET, demonstrating high affi nity binding of these two proteins.
It is important to note that energy transfer between donors and acceptors that are randomly distributed in solutions would occur at a concentration much higher (mM) than used in this experiment (nanomolar to micromolar). The critical concentration (C 0 ) at which the acceptor concentration would result in 76% energy transfer can be calculated from the expression C 0 = 447/R 0 3 . Using the Förster distance R 0 = 50Å for the Cy3/Cy5 pair, the critical concentration would be C 0 = 3.6 mM. Also, diffusion-enhanced energy transfer would not be considered a factor as the lifetimes of Cy3 and Cy5 are in the ns range ( 33 ) . Since FRET can only occur at an optimal distance (1-100Å) ( 33 ), molereceptor (PPAR ␣ or SREBP-1a) and Cy5 for the LCFA/ LCFA-CoA binding protein (L-FABP). Labeling ratios of fl uorescent dye/protein were maintained low (1.1 for Cy3-labeled PPAR ␣ ; 0.8 for Cy5-labeled L-FABP; 1.0 for Cy3-labeled SREBP-1a) to assure essentially 1 tag/protein on average. First, to determine if L-FABP binding altered the conformation of PPAR ␣ , the fl uorescence emission of Cy3-labeled PPAR ␣ was determined in the absence ( Fig. 3A , solid line) and presence ( Fig. 3A , dashed line) of an equal molar amount of L-FABP. The addition of L-FABP slightly decreased the emission of Cy3-PPAR ␣ . Second, in the converse experiment to determine if PPAR ␣ binding altered the conformation of L-FABP, the fl uorescence emission of Cy5-labeled L-FABP was determined in the absence ( Fig. 3B , solid line) and presence ( Fig. 3B , dashed line) of PPAR ␣ . PPAR ␣ increased and red-shifted the emission of Cy5-L-FABP, further confi rming that the interaction of these two proteins result in altered conformational structures. Third, to ensure that this effect was due to binding and not an effect of the dye, the effect of L-FABP on Cy3-labeled SREBP-1a ( Fig. 3C ) and the effect of SREBP-1a on Cy5-labeled L-FABP ( Fig. 3D ) were examined. In both instances, no changes were noted. These data further supported the conformational change seen by CD and suggested that the addition of the small dye molecules (at approximately 1:1 dye to protein ratio) does not interfere with such conformational changes. This is similar to previous data with another nuclear receptor and lipid binding protein showing that the presence of Cy3 or Cy5 dye molecules does not alter protein-protein interactions or ligand binding ( 24 ) .
FRET: Direct interaction between pure recombinant PPAR ␣ and L-FABP proteins
To determine the affi nity of PPAR ␣ for L-FABP and the distance between these proteins, an in vitro FRET experiment was performed with the fl uorescently labeled proteins mentioned above. Cy3 and Cy5 dyes are small (less than 1 kDa) fl uorescent tags that form an effi cient FRET donor/acceptor pair ( 22, 32 ) . The donor (Cy3-PPAR ␣ ) TABLE 1. Secondary structures of PPAR ␣ , L-FABP, SREBP-1a, and complexes of these proteins in the absence and presence of palmitic acid (C16:0) cules farther apart than 100Å will not undergo energy transfer. So although the exact location of the dye on each molecule of protein is unknown, these data are an average of the interactions from all of the labeled molecules and suggest that the overall average is in close molecular proximity.
Co-immunoprecipitation: Direct interaction of L-FABP and PPAR ␣ in liver homogenates
To determine whether the direct interaction of L-FABP and PPAR ␣ seen in vitro could occur in vivo, native proteins were immunoprecipitated from liver homogenates of L-FABP +/+ ( Fig. 4A and B , lanes 1-3) and L-FABP Ϫ / Ϫ ( Fig. 4A and B , lanes 4-6) mice. Whether anti-L-FABP ( Fig. 4A ) or anti-PPAR ␣ ( Fig. 4B ) Although both GR and SREBP-1 proteins were detected in liver homogenate ( Fig. 4C , lane 3) , neither protein was co-immunoprecipitated with PPAR ␣ ( Fig. 4C , lane 1) or L-FABP ( Fig. 4C , lane 2) . To further confi rm the L-FABP specifi city for PPAR ␣ versus other transcription factors, wild-type (L-FABP +/+ ) liver homogenates were also immunoprecipitated with antibodies to GR and SREBP-1, followed by Western blotting to probe for co-immunoprecipitated L-FABP ( Fig. 4D ) . As a positive control, L-FABP was detected prominently in liver homogenates ( Fig. 4D , lane 3) . L-FABP did not co-immunoprecipitate with antibodies to either of these other transcription factors (GR, Fig. 4D , lane 1; SREBP-1 and Fig. 4D , lane 2) , suggesting that even though co-IP experiments tend to have some artifacts, the L-FABP interaction with PPAR ␣ seems specifi c. These data also suggest that the presence of palmitic acid does not inhibit or alter L-FABP interaction with PPAR ␣ .
Immunoelectron microscopy of fi xed hepatocytes: direct L-FABP and PPAR ␣ interaction
For L-FABP expression to infl uence PPAR ␣ transcriptional activity in vivo, L-FABP would need to directly interact with PPAR ␣ in the nucleus. To determine if L-FABP and PPAR ␣ are in suffi ciently close physical proximity for direct interaction within hepatic nuclei, hepatocytes from L-FABP +/+ and L-FABP Ϫ / Ϫ mice were examined by double immunolabeling electron microscopy. These studies revealed two important observations: antigenic sites of L-FABP (6 nm gold particle size) were observed in nuclei of cultured mouse primary hepatocytes from L-FABP +/+ ( Fig. 5A , small gold particles, shown as small black dots located within the circled regions of the nucleus) but not in L-FABP Ϫ / Ϫ (not shown) mice. Likewise, L-FABP (6 nm gold particles) was also detected outside the nucleus in the cytoplasm ( Fig. 5A , small gold particles, shown as small black dots located outside of the nucleus). Examination of multiple hepatocytes (n = 21) revealed that the anti-L-FABP 6 nm gold particle density in the nucleoplasm was not signifi cantly different from that in the cytoplasm 
Statistical analysis demonstrated signifi cant numbers of L-FABP and PPAR ␣ within a distance of 10 nm of each other but found no signifi cant colocalization of LFABP and SREBP-1.
L-FABP, liver fatty acid binding protein; NS, not signifi cant; PPAR ␣ , peroxisome proliferator-activated receptor-␣ ; SREBP-1, sterol regulatory element-binding protein-1. mice, accounted for 7% and 8% of the particle density in nucleoplasm and cytoplasm, respectively ( Fig. 5C ). Importantly, double immunogold electron microscopy of antigenic sites of L-FABP (6 nm gold particle size) and PPAR ␣ (15 nm gold particle size) showed that the L-FABP in nuclei of hepatocytes from L-FABP +/+ was signifi cantly colocalized with PPAR ␣ as shown in the boxed area ( Fig. 5A ) , which was further examined under high magnifi cation ( Fig. 5B ) . Seven regions of colocalizing L-FABP (6 nm gold particle size) with PPAR ␣ (15 nm gold particle size) were subsequently magnifi ed 2.5× to more effectively visualize the two sizes of gold particles ( Fig. 5B, boxes on  right ) . The statistical signifi cance of the colocalization of L-FABP with PPAR ␣ and SREBP-1 (control) was further examined and revealed that the greatest probability of fi nding L-FABP was within 0-10 nm from PPAR ␣ , in contrast to a null probability of fi nding L-FABP in close proximity of SREBP-1 ( Table 2 ) . Using closest pairs, a mean separation distance from edge to edge between the colocalizing gold particles was within 40 ± 5 Å (n = 21). Small amounts of PPAR ␣ also appeared in the cytoplasm colocalized with L-FABP ( Fig. 5A , areas outside of the nucleus where large and small gold particles are in close proximity, shown as large and small black dots, respectively). Subsequently, control experiments for antibody Immunofl uorescence confocal microscopy and FRET in fi xed hepatocytes: direct interaction between L-FABP and PPAR ␣ Although confocal imaging of transfected cells overexpressing L-FABP detected L-FABP in nuclei where it colocalized with PPAR ␣ ( 12 ), the resolution of confocal microscopy alone is insuffi cient to determine if L-FABP and PPAR ␣ are in suffi ciently close physical proximity for direct interaction. Therefore to further confi rm the interaction in nuclei between L-FABP and PPAR ␣ indicated by electron microscopy, hepatocytes were examined by double immunolabeling fl uorescence confocal microscopy and FRET. Since FRET effi ciency varies inversely as the sixth root of intermolecular distance, L-FABP and PPAR ␣ must be in close proximity (i.e., 0-100Å) for efficient FRET to occur.
The data revealed two important observations. First, Cy3-anti-L-FABP detected L-FABP in both the nuclei and cytoplasm as shown by a representative image of Cy3-anti-L-FABP in cultured mouse primary hepatocytes ( Fig. 6A , white pixels) upon excitation of the Cy3 dye. Quantitative analysis of multiple images showed that the ratio of Cy3-anti-L-FABP intensity in the cytoplasm/nucleoplasm was 1.64 ± 0.14 (n = 5). Second, double immunolabeling FRET confocal microscopy showed signifi cant FRET between Cy3-anti-L-FABP and Cy5-anti-PPAR ␣ in the nucleus ( Fig. 6B , blue/green pixels); with the area of highest energy transfer shown within the red box in Fig. 6A . In this experiment, FRET was performed by measuring the increase in intensity of Cy3-anti-L-FABP in the nucleus after photobleaching the acceptor Cy5-anti-PPAR ␣ ( Fig. 6B ) compared with the Cy3-anti-L-FABP intensity before photobleaching the acceptor Cy5-anti-PPAR ␣ ( Fig. 6A ) . Cy5-anti-PPAR ␣ emission upon excitation of the Cy5 dye at 647 nm is shown as a control to ensure that the bleach pulse was suffi ciently powerful to completely bleach the Cy5-anti-PPAR ␣ emission ( Fig. 6D , area inside the dotted box) compared with the Cy5-anti-PPAR ␣ intensity before photobleaching the Cy5-anti-PPAR ␣ acceptor ( Fig. 6C ) . Quantitative analysis of multiple regions of highest FRET in nuclei showed that the closest intermolecular distance between Cy3-anti-L-FABP and Cy5-anti-PPAR ␣ was 49.2 ± 2.8 Å (n = 26).
Although hepatocytes stained with Cy3-anti-L-FABP and Cy5-anti-SREBP-1 show similar distributions of L-FABP between the cytoplasm and nucleoplasm ( Fig. 6E ) , very few pixels colocalize in the nucleus (data not shown), and no signifi cant FRET is noted within nuclei ( Fig. 6F ) . Images of the Cy5-anti-SREBP-1 show that the bleach pulse was sufficiently powerful to completely bleach the Cy5-anti-SREBP-1 emission ( Fig. 6H , area inside the dotted box) compared with the intensity before photobleaching the Cy5-anti-SREBP-1 ( Fig. 6G ) . Quantitative analysis of multiple nuclear chrome C, 13 kDa) diffuse freely through the nuclear pores (90 Å diameter), L-FABP is suffi ciently small to passively diffuse through nuclear pores. Passive distribution of L-FABP between the nucleus and cytoplasm is also supported by fi ndings with transfected L-cell fi broblasts overexpressing L-FABP ( 12 ) . Although L-FABP levels were from 5-to 10-fold lower in transfected L-cells overexpressing L-FABP than in liver hepatocytes, the proportion of nuclear-to-cytoplasmic L-FABP levels were again nearly the same as in hepatocytes.
Third, L-FABP and PPAR ␣ interact in vivo and are in close molecular proximity in hepatocyte nuclei. Both L-FABP and PPAR ␣ antibodies were able to co-immunoprecipitate the respective protein from mouse liver homogenates, in both the presence and absence of palmitic acid. Double immunogold labeling electron microscopy detected signifi cant clustering of L-FABP with PPAR ␣ in hepatocyte nuclei, with a mean separation distance of 40 ± 5 Å. This fi nding was further confi rmed by double immunofl uorescence FRET confocal microscopy, which estimated the intermolecular distance to be 49.2 ± 2.8 Å, similar to that obtained for the recombinant proteins in solution. The interaction of L-FABP with PPAR ␣ was specifi c, as no interaction between L-FABP and SREBP-1a was observed by any of these methods.
The results of these studies may contribute to our understanding of lipid disorders in humans. For example, human variants in the L-FABP gene exhibit elevated fasting LDL-cholesterol and triglyceride levels-traits associated with increased risk of CVD, type 2 diabetes, and metabolic syndrome ( 35, 36 ) . This phenotype was exacerbated by treatment with fenofi brate ( 36 ) . The genetic mutations PPAR ␣ L162V and L-FABP T94A together show a synergistic effect on the basal metabolic index in humans, suggesting that the L-FABP T94A missense mutation might infl uence obesity indices and increase the risk of residual hypertriglyceridemia following a lipid lowering therapy with fenofi brate ( 36 ) . Finally, increased L-FABP expression is associated with insulin-dependent diabetes and gestational diabetes in humans, streptozotocin-induced diabetes or obesity in rats, and type 1 diabetes in mice (37) (38) (39) (40) .
In summary, these new in vitro and imaging experiments demonstrate a high affi nity, structural molecular interaction of L-FABP with PPAR ␣ and suggest a functional role for L-FABP interaction with PPAR ␣ in LCFA metabolism. The potential importance of this interaction is underscored by studies with the closely related cellular retinoic acid binding protein-1 and -2 (CRABP-1 and CRABP-2) and retinoid X receptor ( 5, 41, 42 ) . The latter studies showed that CRABP-2 (but not CRABP-1) binds to retinoid X receptor (RXR) and distributes to the nucleus. Thus, direct interaction of L-FABP with PPAR ␣ may determine L-FABP distribution to the nucleus, facilitate delivery of L-FABP bound ligand (LCFA, LCFA-CoA) into the nucleus, and potentially directly channel L-FABP bound ligand to PPAR ␣ . In support of this possibility, the intermolecular distance observed between L-FABP and PPAR ␣ (i.e., 40-50 Å) was in the same range as reported for PPAR ␣ intrinsic aromatic amino acids and bound fl uorescent ligands such as transregions showing the highest FRET had a maximal energy transfer of less than 1%, and no intermolecular distance between Cy3-anti-L-FABP and Cy5-anti-SREBP-1 could be calculated. In summary, the immunofl uorescence FRET confocal imaging studies were overall consistent with the results above involving electron microscopy; i.e., L-FABP was signifi cantly present in nuclei where it clustered in suffi ciently close proximity (within a few Å) for direct interaction between L-FABP and PPAR ␣ .
DISCUSSION
It has been postulated that L-FABP may play a longeracting role in regulating hepatic fatty acid oxidation/metabolism by participating in an intricate interplay be tween both cytoplasmic (e.g., L-FABP) and nuclear receptor (e.g., PPAR ␣ ) proteins that bind and are activated by LCFA and LCFA-CoA ( 5, 6, 8, 13 ) . In this scheme, it is hypothesized that L-FABP binds and cotransports the bound ligands into the nucleus for direct interaction with PPAR ␣ to induce PPAR ␣ transcription of the gene encoding L-FABP itself (i.e., coordinated regulation) and numerous genes encoding enzymes/proteins involved in LCFA oxidation and gluconeogenesis. While appealing, this hypothesis is based largely on assays performed in vitro with transfected cells overexpressing L-FABP in culture. The present work provides studies with purifi ed recombinant L-FABP and PPAR ␣ , fl uorescently-labeled L-FABP and PPAR ␣ proteins, and double immunolabeling imaging experiments in hepatocytes from wild-type L-FABP (+/+) and gene ablated L-FABP ( Ϫ / Ϫ ) mice that yield signifi cant new mechanistic insights into this evolving hypothesis.
First, L-FABP and PPAR ␣ were shown to directly interact in vitro. These two proteins were each able to pull down the other protein in pure protein co-immunoprecipitation studies. CD and fl uorescence spectroscopy of recombinant proteins showed that L-FABP interaction with PPAR ␣ elicited small but signifi cant alterations in the conformation of both proteins. Moreover, in vitro FRET studies showed that PPAR ␣ bound L-FAPB with high affi nity ( K d = 156.5 ± 18.1 nM) and in close molecular proximity (average intermolecular distance of 52 ± 1Å). Furthermore, CD and co-IP results were unaltered by the presence of palmitic acid, a LCFA known to interact with L-FABP ( 31 ) but not PPAR ␣ ( 6, 7 ). This suggests that structural studies regarding the interaction of L-FABP with PPAR ␣ are physiologically relevant even in the absence of endogenous ligands. However, the effect of these interactions in the presence of ligands bound with high affi nity by both proteins remains to be elucidated.
Second, double immunogold electron microscopy and double immunofl uorescence confocal FRET microscopy detected L-FABP in nuclei at relatively high amounts as shown by cytoplasm-to-nucleus ratios between 1 and 1.6. While the mechanism in which L-FABP distributes into the nucleus has not yet been resolved, either passive diffusion or bidirectional active transport may contribute. Since the hydrodynamic diameter of L-FABP (14 kDa) is only about 36 Å ( 31, 34 ) and other small proteins (e.g., cyto-
